{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:30:18Z","timestamp":1795084218252,"version":"4.10.2"},"reference-count":0,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2003,10,30]],"date-time":"2003-10-30T00:00:00Z","timestamp":1067472000000},"content-version":"vor","delay-in-days":2220,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[1997,10]]},"abstract":"<jats:p>HIV\u2010disease progression in terms of the decline in CD4<jats:sup>+<\/jats:sup> cell count, the development of AIDS\u2010related symptoms and death was studied in 100 Swedish HIV\u2010positive haemophiliacs and correlated to age and haemophilia treatment.<\/jats:p><jats:p>On average 15 years after seroconversion, 66% of the patients had CD4<jats:sup>+<\/jats:sup> cell counts of &lt;\u2003200\u00d710<jats:sup>6<\/jats:sup> L<jats:sup>\u22121<\/jats:sup>, 48% had developed AIDS and 56% had died. Age was found to correlate to all three endpoints, also after adjustment for age, annual clotting factor concentrate (CFC) consumption and HIV\u2010related therapy, i.e. pneumocystis prophylaxis and antiretroviral drugs (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). Total annual CFC consumption showed no significant relationship to the decline in CD4<jats:sup>+<\/jats:sup> cell counts but was inversely correlated to both the development of AIDS\u2010related symptoms (<jats:italic>P<\/jats:italic>\u2003=\u20030.033) and mortality (<jats:italic>P<\/jats:italic>\u2003=\u20030.014). Prophylactic treatment was not associated with significantly better survival than on\u2010demand treatment after adjustment for age, CFC consumption and HIV\u2010therapy. The use of monoclonal\u2010antibody\u2010purified CFCs was not found to stabilize the decline in CD4<jats:sup>+<\/jats:sup> cell counts. However, the use of these CFCs was inversely correlated both to the development of AIDS\u2010related symptoms and to mortality (<jats:italic>P<\/jats:italic>\u2003=\u20030.042 and 0.027, respectively). A similar trend was associated with the use of low\u2010 and intermediate\u2010purity CFCs. As compared with the severe haemophilia A subgroup, the moderate haemophilia A patients showed a trend toward slower disease progression, possibly attributable to a lower incidence of haemarthrosis and arthropathy among the latter.<\/jats:p><jats:p>We conclude that replacement therapy in HIV\u2010infected haemophiliacs is important also for HIV\u2010disease progression, whereas the purity of the CFCs and the regimen used are of minor importance.<\/jats:p>","DOI":"10.1046\/j.1365-2516.1997.00122.x","type":"journal-article","created":{"date-parts":[[2003,11,2]],"date-time":"2003-11-02T15:01:26Z","timestamp":1067785286000},"page":"277-282","source":"Crossref","is-referenced-by-count":5,"title":["HIV\u2010disease progression in Swedish haemophiliacs and the influence of replacement therapy"],"prefix":"10.1111","volume":"3","author":[{"given":"J.","family":"Astermark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Johnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Stigendal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lethagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Berntorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,10,30]]},"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2516.1997.00122.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2516.1997.00122.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T13:59:27Z","timestamp":1698415167000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2516.1997.00122.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,10]]}},"alternative-id":["10.1046\/j.1365-2516.1997.00122.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2516.1997.00122.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}